HemaSource, Inc.

HemaSource is a healthcare logistics company based in the US, focusing on delivering quality medical products and innovative software solutions to specialty ambulatory clinics, enhancing inventory management and operational efficiency. Founded in 1998 and headquartered in Salt Lake City, US, HemaSource provides logistics solutions for the healthcare sector. The company has undergone pivotal changes to enhance its service offerings. It has completed a total of 4 deals, with the most recent occurring on July 20, 2017, when Ridgemont Equity Partners acquired HemaSource Intermediate Holdings, LLC.

The current CEOs are Todd Tracey and Tom Jordan. HemaSource specializes in innovative logistics solutions and high-quality medical products for specialty ambulatory clinics. Its core offerings include the patented ACE™ software, designed for web-based ordering and analytics, which optimizes inventory management for healthcare providers by auto-calculating inventory requirements to minimize waste. Additionally, HemaSource provides a comprehensive catalog of medical disposables and related equipment tailored for plasma collection centers and multi-center healthcare organizations in the US.

HemaSource generates revenue through a business-to-business model, primarily from software subscriptions and sales of medical disposables. Clients utilize the ACE™ software to manage inventory efficiently and engage in recurring transactions for medical supplies tailored to their operational needs. Looking ahead, HemaSource plans to enhance its product line with upcoming releases and expand into new geographic markets. Recent funding from the acquisition in July 2017 will support these initiatives, although specific new products and regions have not yet been disclosed.